Taming the SHREW. SDTM Heuristic Research and Evaluation Workshop
|
|
- Edgar Lambert
- 5 years ago
- Views:
Transcription
1 Taming the SHREW SDTM Heuristic Research and Evaluation Workshop September 13, 2013 Carlo Radovsky
2 2 Overview Introductions The Backstory CDISC IntraChange History of a Rule The Challenge Discuss Amongst Ourselves
3 3 Introductions Carlo Radovsky Member of FDA/PhUSE DVQA (Data Validation and Quality Assessment) Working Group Member of CDISC SDS Team Anne Russotto PhUSE Steering Committee Liaison to DVQA Working Group Max Kanevsky Industry Co-Lead for FDA/PhUSE DVQA Working Group Solution Architect for FDA DataFit OpenCDISC
4 4 Backstory: CDISC IntraChange CDISC IntraChange 2013: July 30 August 1 CDISC teams meet internally as well as interact with other to address common challenges and goals Goal is to make progress on key 2013 deliverables, and to raise awareness of all teams on major issues and topics affecting us all Work together, learn from each other, solve problems, make progress, and identify new volunteers - Source: IntraChange 2013 Opening Plenary, Wayne Kubick
5 5 Backstory: CDISC IntraChange Cross-Team Session 5 (XT5): Validation Conformance Requirements Agenda Item 1: What are the obligations of CDISC teams when publishing new standards? Agenda Item 2: How do SDOs, sponsors, industry groups and vendors interact to work toward a better standards process for validation requirements? Agenda Item 3: Standards Governance Agenda Item 4: Standards validation Forum, a place where checks can be discussed currently takes place via PhUSE Data Quality Working Group - Source: XT5 - Validation Conformance Requirements Session Summary, Frank Newby
6 6 Backstory: CDISC IntraChange XT5 Item 1: What are the obligations of CDISC teams when publishing new standards? CDISC teams own/drive conformance requirements Conformance requirements should be called out explicitly within specification and IG documents Highlighted, linked, etc. A separate conformance document needs to be prepared (e.g., the ADaM, Define, and SEND teams material) - Source: XT5 - Validation Conformance Requirements Session Summary, Frank Newby
7 7 Backstory: CDISC IntraChange XT5 Item 2: How do SDOs, sponsors, industry groups and vendors interact to work toward a better standards process for validation requirements? FDA/PhUSE DVQA Working Group a common place for finding all of the Rules for a standard and will support the governance process Liaisons to be identified to participate and exchange information between working group and CDISC teams - Source: XT5 - Validation Conformance Requirements Session Summary, Frank Newby
8 8 Backstory: CDISC IntraChange XT5 Item 3: Standards Governance Work with PhUSE group to determine governance process and SMEs involved if deemed necessary For newly defined standards, identify where in the CDISC development process conformance requirements are established Determine relationship to data quality/submission rules and who owns those Any governance should be simple, straightforward - Source: XT5 - Validation Conformance Requirements Session Summary, Frank Newby
9 9 Backstory: CDISC IntraChange XT5 Item 4: Standards validation Forum Engage with PhUSE to determine how CDISC can best leverage the Data Quality Working Group wiki as a discussion forum - Source: XT5 - Validation Conformance Requirements Session Summary, Frank Newby
10 10 Backstory: CDISC IntraChange Obvious Gap: SDTM conformance requirements How to address?
11 11 Backstory: History of a Rule Original SDTM rule set developed for FDA JANUS Vendors implemented these rules, extending based on operational needs and additional understanding of model OpenCDISC started there, but more recently has been working with PhUSE and FDA to develop additional checks
12 12 Backstory: History of a Rule Rule Then & Now Attribute JANUS OpenCDISC Rule ID IR4000 SD0001 SDTM Version 3.1/ /3.1.2/3.1.3 (per ruleset) Effective Date Category Description Identifies domain table that has zero rows and therefore contains no data Presence Severity Low Warning Domain table should have at least one record Error Message No rows in domain table No records in data source Impact Study loaded and error noted in error report
13 13 Backstory: History of a Rule Rule Then & Now JANUS, ADaM identify failure criteria Attribute Useful, how about JANUS rule OpenCDISC version? OpenCDISC has success Rule ID IR4000 SD0001 SDTM Version 3.1/ /3.1.2/3.1.3 (per ruleset) Effective Date Category Description Identifies domain table that has zero rows and therefore contains no data Presence Severity Low Warning Domain table should have at least one record Error Message No rows in domain table No records in data source Impact Study loaded and error noted in error report
14 14 Backstory: History of a Rule Rule Then & Now Attribute JANUS OpenCDISC Rule ID IR4000 SD0001 JANUS terms not necessarily relevant OpenCDISC terms self evident SDTM Version 3.1/3.1.1 (Error, Warning, 3.1.1/3.1.2/3.1.3 Informational) High: Prevents JANUS loading (per ruleset) Medium: Effective Impacts Date reviewability Generally assess impact for end-user Low: Category May impact reviewability Both Warning and Error require resolution Presence or explanation to FDA Description Identifies domain table that has Distinct Domain but, how table operationally should have zero rows and therefore different? at least one record contains no data Severity Low Warning Error Message No rows in domain table No records in data source Impact Study ADaM loaded Team and did error not define noted severity in error Define report Team?
15 15 Backstory: History of a Rule CDISC References SDTM IG 3.1.2/3.1.3, Section 3.2, p. 17: In the event that no records are present in a dataset (e.g., a small PK study where no subjects took concomitant medications), the empty dataset should not be submitted and should not be described in the define.xml document. The annotated CRF will show the data that would have been submitted had data been received; it need not be re-annotated to indicate that no records exist. SDTM Metadata Submission Guide, Section 3.2, p. 8: In the event that no records are present in a dataset (e.g., a small study where no subjects took concomitant medications), the empty dataset should not be submitted or described in the define.xml. Please refer to Section for information regarding the annotations of such a dataset. SDTM Metadata Submission Guide, Section 4.1.1, p. 17: In the event that a dataset is not submitted because it is empty, the annotated CRF will show the annotations for the data that would have been submitted had data been received; it is not necessary to return to the CRF post data collection and change the annotation to indicate that no records were collected.
16 16 Backstory: History of a Rule CDISC References Rule 2 Rule 1 Seems Warning from end-user perspective Error from Conformance perspective? SDTM IG 3.1.2/3.1.3, Section 3.2, p. 17: In the event that no records are present in a dataset (e.g., a small PK study where no subjects took concomitant medications), the empty dataset should not be submitted and should not be described in the define.xml document. The annotated CRF will show the data that would have been submitted had data been received; it need not be re-annotated to indicate that no records exist. SDTM Metadata Submission Guide, Section 3.2, p. 8: Rule 3 (not machine-testable) In the event that no records are present in a dataset (e.g., a small study where no subjects took concomitant medications), the empty dataset should not be submitted or described in the define.xml. Please refer to Section for information regarding the annotations of such a dataset. SDTM Metadata Submission Guide, Section 4.1.1, p. 17: In the event that a dataset is not submitted because it is empty, the annotated CRF will show the annotations for the data that would have been submitted had data been received; it is not necessary to return to the CRF post data collection and change the annotation to indicate that no records were collected.
17 17 The Challenge: SDTM Conformance Rules Lessons Learned from ADaM and Define Teams Tremendous amount of work Lots of discussion/debate
18 18 The Challenge: SDTM Conformance Rules What is different (maybe?) Existing references JANUS CAB Validation Project OpenCDISC Others? Upcoming FDA Technical Conformance document? Broader/Deeper SME community
19 Discuss Amongst Ourselves 19
Study Data Reviewer s Guide. FDA/PhUSE Project Summary
Study Data Reviewer s Guide FDA/PhUSE Project Summary Agenda FDA/PhUSE Collaboration Overview Study Data Reviewer s Guide (SDRG) Project Summary FDA/PhUSE Collaboration FDA Proclamation We the Masses Yearning
More informationOpenCDISC Validator 1.4 What s New?
OpenCDISC Validator 1.4 What s New? Bay Area CDISC Implementation Network 23 May 2013 David Borbas Sr Director, Data Management Jazz Pharmaceuticals, Inc. Disclaimers The opinions expressed in this presentation
More informationBeyond OpenCDISC: Using Define.xml Metadata to Ensure End-to-End Submission Integrity. John Brega Linda Collins PharmaStat LLC
Beyond OpenCDISC: Using Define.xml Metadata to Ensure End-to-End Submission Integrity John Brega Linda Collins PharmaStat LLC Topics Part 1: A Standard with Many Uses Status of the Define.xml Standard
More informationLex Jansen Octagon Research Solutions, Inc.
Converting the define.xml to a Relational Database to enable Printing and Validation Lex Jansen Octagon Research Solutions, Inc. Leading the Electronic Transformation of Clinical R&D PhUSE 2009, Basel,
More informationCDISC Standards and the Semantic Web
CDISC Standards and the Semantic Web Dave Iberson-Hurst 12 th October 2015 PhUSE Annual Conference, Vienna 1 Abstract With the arrival of the FDA guidance on electronic submissions, CDISC SHARE and the
More informationOptimization of the traceability when applying an ADaM Parallel Conversion Method
SI04 Optimization of the traceability when applying an ADaM Parallel Conversion Method Roxane Debrus ADaM Conversion Process Agenda %LIB_QC_contents_html %adam_sdtm_compa Conclusion ADaM Conversion Process
More informationImproving Metadata Compliance and Assessing Quality Metrics with a Standards Library
PharmaSUG 2018 - Paper SS-12 Improving Metadata Compliance and Assessing Quality Metrics with a Standards Library Veena Nataraj, Erica Davis, Shire ABSTRACT Establishing internal Data Standards helps companies
More informationStudy Data Reviewer s Guide Completion Guideline
Study Data Reviewer s Guide Completion Guideline 22-Feb-2013 Revision History Date Version Summary 02-Nov-2012 0.1 Draft 20-Nov-2012 0.2 Added Finalization Instructions 10-Jan-2013 0.3 Updated based on
More informationHow to write ADaM specifications like a ninja.
Poster PP06 How to write ADaM specifications like a ninja. Caroline Francis, Independent SAS & Standards Consultant, Torrevieja, Spain ABSTRACT To produce analysis datasets from CDISC Study Data Tabulation
More informationCreating Define-XML v2 with the SAS Clinical Standards Toolkit 1.6 Lex Jansen, SAS
Creating Define-XML v2 with the SAS Clinical Standards Toolkit 1.6 Lex Jansen, SAS Agenda Introduction to the SAS Clinical Standards Toolkit (CST) Define-XML History and Background What is Define-XML?
More informationStandards Implementation: It Should be Simple Right? Thursday January 18, 2018
Standards Implementation: It Should be Simple Right? Thursday January 18, 2018 Upcoming MassBio Forums January 18, 2018; 4-6pm: TODAY!! 2018 JP Morgan Recap: An Insiders View BD/Fin & EU February 1, 2018;
More informationUpdates on CDISC Standards Validation
Updates on CDISC Standards Validation NJ CDISC User Group September 19, 2013 Topics CDISC standards validation initiative FDA update on SEND checks OpenCDISC v1.4.1 release OpenCDISC plans 2 CDISC validation
More informationPharmaceuticals, Health Care, and Life Sciences. An Approach to CDISC SDTM Implementation for Clinical Trials Data
An Approach to CDISC SDTM Implementation for Clinical Trials Data William T. Chen, Merck Research Laboratories, Rahway, NJ Margaret M. Coughlin, Merck Research Laboratories, Rahway, NJ ABSTRACT The Clinical
More informationEdwin Ponraj Thangarajan, PRA Health Sciences, Chennai, India Giri Balasubramanian, PRA Health Sciences, Chennai, India
Paper CD15 PhUSE 2016 How to handle different versions of SDTM & DEFINE generation in a Single Study? Edwin Ponraj Thangarajan, PRA Health Sciences, Chennai, India Giri Balasubramanian, PRA Health Sciences,
More informationIntroduction to Define.xml
Introduction to Define.xml Bay Area CDISC Implementation Network 4 April 2008 John Brega, PharmaStat LLC Presentation Objectives 1. Introduce the concept and purpose of define.xml 2. Introduce the published
More informationStandards Driven Innovation
Standards Driven Innovation PhUSE Annual Conference 2014 Frederik Malfait IMOS Consulting GmbH, Hoffmann-La Roche AG Managing Standards 2 Data Standards Value Proposition Standards are increasingly mandated
More informationTips on Creating a Strategy for a CDISC Submission Rajkumar Sharma, Nektar Therapeutics, San Francisco, CA
PharmaSUG 2015 - Paper IB09 Tips on Creating a Strategy for a CDISC Submission Rajkumar Sharma, Nektar Therapeutics, San Francisco, CA ABSTRACT A submission to FDA for an NDA (New Drug Application) or
More informationCBER STUDY DATA STANDARDS UPDATE
CBER STUDY DATA STANDARDS UPDATE Lisa Lin, MBA Study Data Standards Manager Office of the Director Center for Biologics Evaluation and Research U.S. Food & Drug Administration PhUSE US Connect Raleigh,
More informationFrom Implementing CDISC Using SAS. Full book available for purchase here. About This Book... xi About The Authors... xvii Acknowledgments...
From Implementing CDISC Using SAS. Full book available for purchase here. Contents About This Book... xi About The Authors... xvii Acknowledgments... xix Chapter 1: Implementation Strategies... 1 Why CDISC
More informationBusiness & Decision Life Sciences
Business & Decision Life Sciences Moving to Define.xml v2.0.0 for CDISC FSUG Anne-Sophie Bekx / 22 May 2014 Introduction Differences Impact Introduction History of Define.xml February 2005: CRT-DDS Final
More informationXiangchen (Bob) Cui, Tathabbai Pakalapati, Qunming Dong Vertex Pharmaceuticals, Cambridge, MA
Building Traceability for End Points in Analysis Datasets Using SRCDOM, SRCVAR, and SRCSEQ Triplet Xiangchen (Bob) Cui, Tathabbai Pakalapati, Qunming Dong Vertex Pharmaceuticals, Cambridge, MA 2010 Vertex
More informationSandra Minjoe, Accenture Life Sciences John Brega, PharmaStat. PharmaSUG Single Day Event San Francisco Bay Area
Sandra Minjoe, Accenture Life Sciences John Brega, PharmaStat PharmaSUG Single Day Event San Francisco Bay Area 2015-02-10 What is the Computational Sciences Symposium? CSS originally formed to help FDA
More informationSubmission-Ready Define.xml Files Using SAS Clinical Data Integration Melissa R. Martinez, SAS Institute, Cary, NC USA
PharmaSUG 2016 - Paper SS12 Submission-Ready Define.xml Files Using SAS Clinical Data Integration Melissa R. Martinez, SAS Institute, Cary, NC USA ABSTRACT SAS Clinical Data Integration simplifies the
More informationDIA 11234: CDER Data Standards Common Issues Document webinar questions
Q: What is the preferred data definition format for ADaM analysis data, define.xml or define.pdf? 1 ADaM Define File Q: The CRTDDS does not describe how to submit a define.xml for ADaM. Does CDER expect
More informationAquila's Lunch And Learn CDISC The FDA Data Standard. Disclosure Note 1/17/2014. Host: Josh Boutwell, MBA, RAC CEO Aquila Solutions, LLC
Aquila's Lunch And Learn CDISC The FDA Data Standard Host: Josh Boutwell, MBA, RAC CEO Aquila Solutions, LLC Disclosure Note This free training session will be placed on Aquila s website after the session
More informationAdding, editing and managing links to external documents in define.xml
SDTM-ETL 3.1 User Manual and Tutorial Author: Jozef Aerts, XML4Pharma Last update: 2015-05-25 Adding, editing and managing links to external documents in define.xml Define.xml contains the metadata of
More informationPMDA Valida+on Rules. Preparing for your next submission to Japanese Pharmaceu6cals and Medical Devices Agency. Max Kanevsky December 10, 2015
PMDA Valida+on Rules Preparing for your next submission to Japanese Pharmaceu6cals and Medical Devices Agency Max Kanevsky December 10, 2015 Presenter Max Kanevsky Founder of OpenCDISC CEO of Pinnacle
More informationPhUSE Paper SD09. "Overnight" Conversion to SDTM Datasets Ready for SDTM Submission Niels Mathiesen, mathiesen & mathiesen, Basel, Switzerland
Paper SD09 "Overnight" Conversion to SDTM Datasets Ready for SDTM Submission Niels Mathiesen, mathiesen & mathiesen, Basel, Switzerland ABSTRACT This demonstration shows how legacy data (in any format)
More informationOut-of-the-box %definexml
Out-of-the-box %definexml Just a Simple SAS Macro PhUSE / October 2016 / Katja Glaß Agenda Introduction Getting Started %DefineXML Collaborate Summary Page 2 DefineXML Katja Glaß 11. October 2016 Introduction
More informationSDTM-ETL TM. New features in version 1.6. Author: Jozef Aerts XML4Pharma July SDTM-ETL TM : New features in v.1.6
SDTM-ETL TM New features in version 1.6 Author: Jozef Aerts XML4Pharma July 2011 p.1/14 Table of Contents Implementation of SEND v.3.0 final...3 Automated creation of the RELREC dataset and records...4
More informationCDASH MODEL 1.0 AND CDASHIG 2.0. Kathleen Mellars Special Thanks to the CDASH Model and CDASHIG Teams
CDASH MODEL 1.0 AND CDASHIG 2.0 Kathleen Mellars Special Thanks to the CDASH Model and CDASHIG Teams 1 What is CDASH? Clinical Data Acquisition Standards Harmonization (CDASH) Standards for the collection
More informationChallenges with the interpreta/on of CDISC - Who can we trust?
Challenges with the interpreta/on of CDISC - Who can we trust? Linda Palm Simonsson linda.simonsson@i- mind.se CD01 #PhUSE14 - London 2014-10- 13 Abstract Many smaller companies have none or very linle
More informationLegacy to SDTM Conversion Workshop: Tools and Techniques
Legacy to SDTM Conversion Workshop: Tools and Techniques Mike Todd President Nth Analytics Legacy Data Old studies never die Legacy studies are often required for submissions or pharmacovigilence. Often
More informationWhat is high quality study metadata?
What is high quality study metadata? Sergiy Sirichenko PhUSE Annual Conference Barcelona, 2016 What is study metadata? Trial Design domains Reviewer s Guides acrf Define.xml Conclusion Topics What is study
More informationClinical Metadata Metadata management with a CDISC mindset
Paper SI02 Clinical Metadata Metadata management with a CDISC mindset Andrew Ndikom, Clinical Metadata, London, United Kingdom Liang Wang, Clinical Metadata, London, United Kingdom ABSTRACT Metadata is
More informationLex Jansen Octagon Research Solutions, Inc.
Converting the define.xml to a Relational Database to Enable Printing and Validation Lex Jansen Octagon Research Solutions, Inc. Leading the Electronic Transformation of Clinical R&D * PharmaSUG 2009,
More informationImplementing CDISC Using SAS. Full book available for purchase here.
Implementing CDISC Using SAS. Full book available for purchase here. Contents About the Book... ix About the Authors... xv Chapter 1: Implementation Strategies... 1 The Case for Standards... 1 Which Models
More informationDealing with changing versions of SDTM and Controlled Terminology (CT)
CDISC UK Network Breakout session Notes 07/06/16 Afternoon Session 1: Dealing with changing versions of SDTM and Controlled Terminology (CT) How do people manage this? Is this managed via a sponsor Standards
More informationBay Area CDISC Network: PhUSE Working Group for Inspection Site Selection Data Standards
Bay Area CDISC Network: PhUSE Working Group for Inspection Site Selection Data Standards Patricia Gerend Genentech, Inc., A Member of the Roche Group 30 April 2015 Agenda Page 2 Introduction to PhUSE Working
More informationStudy Data Reviewer s Guide
Revision History Date Study Data Reviewer s Guide Completion Guideline: Nonclinical (nnsdrg) Version Summary V1.1 03 March 2016 1.0 First Public Version: posted for Public Comment 1.1 Update from Public
More informationADaM Compliance Starts with ADaM Specifications
PharmaSUG 2017 - Paper DS16 ADaM Compliance Starts with ADaM Specifications Trevor Mankus, Kent Letourneau, PRA Health Sciences ABSTRACT As of December 17th, 2016, the FDA and PMDA require that all new
More informationADaM Reviewer s Guide Interpretation and Implementation
Paper CD13 ADaM Reviewer s Guide Interpretation and Implementation Steve Griffiths, GlaxoSmithKline, Stockley Park, UK ABSTRACT Throughout the course of a study, teams will make a lot of decisions about
More informationSAS Clinical Data Integration 2.4
SAS Clinical Data Integration 2.4 User s Guide SAS Documentation The correct bibliographic citation for this manual is as follows: SAS Institute Inc. 2013. SAS Clinical Data Integration 2.4: User's Guide.
More informationIt s All About Getting the Source and Codelist Implementation Right for ADaM Define.xml v2.0
PharmaSUG 2018 - Paper SS-15 It s All About Getting the Source and Codelist Implementation Right for ADaM Define.xml v2.0 ABSTRACT Supriya Davuluri, PPD, LLC, Morrisville, NC There are some obvious challenges
More informationCDASH Standards and EDC CRF Library. Guang-liang Wang September 18, Q3 DCDISC Meeting
CDASH Standards and EDC CRF Library Guang-liang Wang September 18, 2014 2014 Q3 DCDISC Meeting 1 Disclaimer The content of this presentation does not represent the views of my employer or any of its affiliates.
More informationOrganizing Deliverables for Clinical Trials The Concept of Analyses and its Implementation in EXACT
Paper AD05 Organizing Deliverables for Clinical Trials The Concept of Analyses and its Implementation in EXACT Hansjörg Frenzel, PRA International, Mannheim, Germany ABSTRACT Clinical trials can have deliverables
More informationCDISC Public Webinar Standards Updates and Additions. 26 Feb 2015
CDISC Public Webinar Standards Updates and Additions 26 Feb 2015 CDISC 2014 Agenda SHARE Research Concepts Julie Evans, CDISC Anthony Chow, CDISC Rene Dahlheimer, CDISC Sam Hume, CDISC CDISC Education
More informationSAS offers technology to facilitate working with CDISC standards : the metadata perspective.
SAS offers technology to facilitate working with CDISC standards : the metadata perspective. Mark Lambrecht, PhD Principal Consultant, Life Sciences SAS Agenda SAS actively supports CDISC standards Tools
More informationTraceability Look for the source of your analysis results
Traceability Look for the source of your analysis results Herman Ament, Cromsource CDISC UG Milan 21 October 2016 Contents Introduction, history and CDISC Traceability Examples Conclusion 2 / 24 Introduction,
More informationAdvantages of a real end-to-end approach with CDISC standards
Advantages of a real end-to-end approach with CDISC standards Dr. Philippe Verplancke CEO XClinical GmbH 26th Annual EuroMeeting 25-27 March 2014 ACV, Vienna Austria Disclaimer The views and opinions expressed
More informationOptimizing the Use of Data Standards CSS Summary
Optimizing the Use of Data Standards CSS Summary PhUSE Webinar 26 April 2017 Co-Leads: Susan Kenny (Maximum Likelihood) Jane Lozano (Eli Lilly) Best Prac*ces for Data Collec*on Instruc*ons Project Lead:
More informationThe Wonderful World of Define.xml.. Practical Uses Today. Mark Wheeldon, CEO, Formedix DC User Group, Washington, 9 th December 2008
The Wonderful World of Define.xml.. Practical Uses Today Mark Wheeldon, CEO, Formedix DC User Group, Washington, 9 th December 2008 Agenda Introduction to Formedix What is Define.xml? Features and Benefits
More informationCDISC SDTM and ADaM Real World Issues
CDISC SDTM and ADaM Real World Issues Washington DC CDISC Data Standards User Group Meeting Sy Truong President MXI, Meta-Xceed, Inc. http://www.meta-x.com Agenda CDISC SDTM and ADaM Fundamentals CDISC
More informationDCDISC Users Group. Nate Freimark Omnicare Clinical Research Presented on
DCDISC Users Group Nate Freimark Omnicare Clinical Research Presented on 2011-05-12 1 Disclaimer The opinions provided are solely those of the author and not those of the ADaM team or Omnicare Clinical
More informationManaging CDISC version changes: how & when to implement? Presented by Lauren Shinaberry, Project Manager Business & Decision Life Sciences
1 Managing CDISC version changes: how & when to implement? Presented by Lauren Shinaberry, Project Manager Business & Decision Life Sciences 2 Content Standards Technical Standards SDTM v1.1 SDTM IG v3.1.1
More informationStudy Composer: a CRF design tool enabling the re-use of CDISC define.xml metadata
Paper SD02 Study Composer: a CRF design tool enabling the re-use of CDISC define.xml metadata Dr. Philippe Verplancke, XClinical GmbH, Munich, Germany ABSTRACT define.xml is often created at the end of
More informationStreamline SDTM Development and QC
Paper SI09 Streamline SDTM Development and QC Stephen Gormley, Amgen, United Kingdom ABSTRACT Amgen s Global Statistical Programming ( GSP ) function have one centralised team (The CDISC Consultancy and
More informationPharmaSUG Paper PO22
PharmaSUG 2015 - Paper PO22 Challenges in Developing ADSL with Baseline Data Hongyu Liu, Vertex Pharmaceuticals Incorporated, Boston, MA Hang Pang, Vertex Pharmaceuticals Incorporated, Boston, MA ABSTRACT
More informationSDTM-ETL 3.1 User Manual and Tutorial
SDTM-ETL 3.1 User Manual and Tutorial Author: Jozef Aerts, XML4Pharma Last update: 2014-07-19 Creating mappings for the AE domain Now that we have created (and executed) mappings for several domains, let
More informationClinical Metadata A complete metadata and project management solu6on. October 2017 Andrew Ndikom and Liang Wang
A complete metadata and project management solu6on. October 2017 Andrew Ndikom and Liang Wang 1 Agenda How is metadata currently managed within the industry? Five key problems with current approaches.
More informationDefine.xml 2.0: More Functional, More Challenging
Define.xml 2.0: More Functional, More Challenging Bay Area CDISC Implementation Network 24 July 2013 John Brega, PharmaStat LLC Presentation Objectives 1. Introduce the new features in Define.xml 2.0 with
More informationImproving CDISC SDTM Data Quality & Compliance Right from the Beginning
Improving CDISC Data Quality & Compliance Right from the Beginning Bharat Chaudhary, Cytel Padamsimh Balekundri, Cytel Session CD08 PhUSE 2015, Vienna Agenda Background Overview: Development The Problem:
More informationStandards Metadata Management (System)
Standards Metadata Management (System) Kevin Lee, MarkLogic COPYRIGHT 2015 MARKLOGIC CORPORATION. ALL RIGHTS RESERVED. Agenda Regulatory Requirement on Clinical Trial Standards(i.e., CDISC and ectd) Standards
More informationTS04. Running OpenCDISC from SAS. Mark Crangle
TS04 Running OpenCDISC from SAS Mark Crangle Introduction The OpenCDISC validator is a tool used to check the compliance of datasets with CDISC standards Open-source Freely available and created by team
More informationOn the Horizon: New Trial Summary Dataset (TS)
On the Horizon: New Trial Summary Dataset (TS) Helena Sviglin, Chris Tolk, and Jane Diefenbach DCDISC Meeting at HGSI, Gaithersburg MD November 8, 2011 Presenting. Overview What is it? Where did it come
More informationSAS Clinical Data Integration 2.6
SAS Clinical Data Integration 2.6 User s Guide SAS Documentation The correct bibliographic citation for this manual is as follows: SAS Institute Inc. 2015. SAS Clinical Data Integration 2.6: User's Guide.
More informationOptimization of the traceability when applying an ADaM Parallel Conversion Method
Paper SI04 Optimization of the traceability when applying an ADaM Parallel Conversion Method DEBRUS Roxane, Business & Decision Life Sciences, Brussels, Belgium ABSTRACT One of the methods to create CDISC
More informationPhUSE US Connect 2019
PhUSE US Connect 2019 Paper SI04 Creation of ADaM Define.xml v2.0 Using SAS Program and Pinnacle 21 Yan Lei, Johnson & Johnson, Spring House, PA, USA Yongjiang Xu, Johnson & Johnson, Spring House, PA,
More informationTaming Rave: How to control data collection standards?
Paper DH08 Taming Rave: How to control data collection standards? Dimitri Kutsenko, Entimo AG, Berlin, Germany Table of Contents Introduction... 1 How to organize metadata... 2 How to structure metadata...
More informationHelping The Define.xml User
Paper TT01 Helping The Define.xml User Dave Iberson-Hurst, Assero Limited, Teignmouth, United Kingdom ABSTRACT The FDA often comment at industry gatherings on the quality of define.xml files received as
More informationDataset-XML - A New CDISC Standard
Dataset-XML - A New CDISC Standard Lex Jansen Principal Software Developer @ SAS CDISC XML Technologies Team Single Day Event CDISC Tools and Optimization September 29, 2014, Cary, NC Agenda Dataset-XML
More informationHow to handle different versions of SDTM & DEFINE generation in a Single Study?
Paper CD15 How to handle different versions of SDTM & DEFINE generation in a Single Study? Edwin Ponraj Thangarajan, PRA Health Sciences, Chennai, India Giri Balasubramanian, PRA Health Sciences, Chennai,
More informationStep Up Your ADaM Compliance Game Ramesh Ayyappath & Graham Oakley
Step Up Your ADaM Compliance Game Ramesh Ayyappath & Graham Oakley Accountability & Delivery Collaboration Partnership Integrity Agenda v Regulatory Requirement v Current Situation v iace-toolbox v 3 Step
More informationExperience of electronic data submission via Gateway to PMDA
PharmaSUG 2018 - Paper EP-21 ABSTRACT Experience of electronic data submission via Gateway to PMDA Iori Sakakibara, Kumiko Kimura, Amgen Astellas BioPharma K.K. and Laurence Carpenter, Amgen Ltd PMDA started
More informationMaterial covered in the Dec 2014 FDA Binding Guidances
Accenture Accelerated R&D Services Rethink Reshape Restructure for better patient outcomes Sandra Minjoe Senior ADaM Consultant Preparing ADaM and Related Files for Submission Presentation Focus Material
More informationPhUSE EU Connect 2018 SI05. Define ing the Future. Nicola Perry and Johan Schoeman
PhUSE EU Connect 2018 SI05 Define ing the Future Nicola Perry and Johan Schoeman Introduction Difference s in Define v2 Consistency and Quality Hints and Tips Conclusion 2 Difference s in Define v2 Difference
More informationAutomated Creation of Submission-Ready Artifacts Silas McKee, Accenture, Pennsylvania, USA Lourdes Devenney, Accenture, Pennsylvania, USA
Paper DH06 Automated Creation of Submission-Ready Artifacts Silas McKee, Accenture, Pennsylvania, USA Lourdes Devenney, Accenture, Pennsylvania, USA ABSTRACT Despite significant progress towards the standardization
More informationControlling OpenCDISC using R. Martin Gregory PhUSE 2012 Budapest, October 2012
Controlling OpenCDISC using R Martin Gregory PhUSE 2012 Budapest, October 2012 1 Motivation 2 Solution 3 Details 4 Conclusion Introduction OpenCDISC Validator is a project of OpenCDISC Java application
More informationDoctor's Prescription to Re-engineer Process of Pinnacle 21 Community Version Friendly ADaM Development
PharmaSUG 2018 - Paper DS-15 Doctor's Prescription to Re-engineer Process of Pinnacle 21 Community Version Friendly ADaM Development Aakar Shah, Pfizer Inc; Tracy Sherman, Ephicacy Consulting Group, Inc.
More informationCreating Define-XML version 2 including Analysis Results Metadata with the SAS Clinical Standards Toolkit
Creating Define-XML version 2 including Analysis Results Metadata with the SAS Clinical Standards Toolkit Lex Jansen Principal Software Developer @ SAS PharmaSUG 2016 Agenda Why Analysis Results Metadata?
More informationPaper DS07 PhUSE 2017 CDISC Transport Standards - A Glance. Giri Balasubramanian, PRA Health Sciences Edwin Ponraj Thangarajan, PRA Health Sciences
Paper DS07 PhUSE 2017 CDISC Transport Standards - A Glance Giri Balasubramanian, PRA Health Sciences Edwin Ponraj Thangarajan, PRA Health Sciences Agenda Paper Abstract CDISC Standards Types Why Transport
More informationSemantic Technologies and CDISC Standards. Frederik Malfait, Information Architect, IMOS Consulting Scott Bahlavooni, Independent
Semantic Technologies and CDISC Standards Frederik Malfait, Information Architect, IMOS Consulting Scott Bahlavooni, Independent Part I Introduction to Semantic Technology Resource Description Framework
More informationBUSINESS-BASED VALUE IN AN MDR
MERCK METADATA REPOSITORY: BUSINESS-BASED VALUE IN AN MDR A. Brooke Hinkson Manori Turmel Karl Konrad PhUSE Connect Conference, Raleigh NC, 4-6 June 2018 2 Business Problems to Address Current information
More informationThe application of SDTM in a disease (oncology)-oriented organization
Paper CD01 The application of SDTM in a disease (oncology)-oriented organization Angelo Tinazzi, Alessandro Cattaneo, Enrica Paschetto, Sonia Colombini SENDO-Tech S.r.l., Milan, Italy ABSTRACT Applying
More informationPlanning to Pool SDTM by Creating and Maintaining a Sponsor-Specific Controlled Terminology Database
PharmaSUG 2017 - Paper DS13 Planning to Pool SDTM by Creating and Maintaining a Sponsor-Specific Controlled Terminology Database ABSTRACT Cori Kramer, Ragini Hari, Keith Shusterman, Chiltern When SDTM
More informationComparison of FDA and PMDA Requirements for Electronic Submission of Study Data
Comparison of FDA and PMDA Requirements for Electronic Submission of Study Data Monika Kawohl Statistical Programming Accovion CDISC GSUG Meeting 15-Sep-2015 1 References FDA Website: Study Data Standards
More informationBest Practice for Explaining Validation Results in the Study Data Reviewer s Guide
Paper DS06 Best Practice for Explaining Validation Results in the Study Data Reviewer s Guide Kristin Kelly, Pinnacle 21 LLC, Plymouth Meeting, PA, USA Michael Beers, Pinnacle 21 LLC, Plymouth Meeting,
More informationCommon Programming Errors in CDISC Data
ABSTRACT PharmaSUG 2017 - Paper DS15 Common Programming Errors in CDISC Data Sergiy Sirichenko, Pinnacle 21 Data in standardized format is now a required part of regulatory submissions. CDISC standards
More informationRevision of Technical Conformance Guide on Electronic Study Data Submissions
Notification No. 0824001 August 24, 2016 To: Prefectural Health Department (Bureau) Director of the Advanced Review with Electronic Data Promotion Group, Pharmaceuticals and Medical Devices Agency Revision
More informationCodelists Here, Versions There, Controlled Terminology Everywhere Shelley Dunn, Regulus Therapeutics, San Diego, California
ABSTRACT PharmaSUG 2016 - Paper DS16 lists Here, Versions There, Controlled Terminology Everywhere Shelley Dunn, Regulus Therapeutics, San Diego, California Programming SDTM and ADaM data sets for a single
More informationInternal Audit Follow-Up Report. Multiple Use Agreements TxDOT Office of Internal Audit
Internal Audit Follow-Up Report Multiple Use Agreements TxDOT Office of Internal Audit Objective Assess the status of corrective actions for high risk Management Action Plans (MAPs) previously communicated
More informationIEEE 802 EC ITU standing committee
1 IEEE 802 EC ITU standing committee Glenn Parsons - Ericsson glenn.parsons@ericsson.com +1 613 963 8141 November 2015 2 Agenda for November meeting Role of this standing committee IEEE membership in ITU
More informationTHE DATA DETECTIVE HINTS AND TIPS FOR INDEPENDENT PROGRAMMING QC. PhUSE Bethan Thomas DATE PRESENTED BY
THE DATA DETECTIVE HINTS AND TIPS FOR INDEPENDENT PROGRAMMING QC DATE PhUSE 2016 PRESENTED BY Bethan Thomas What this presentation will cover And what this presentation will not cover What is a data detective?
More informationUse of Traceability Chains in Study Data and Metadata for Regulatory Electronic Submission
PharmaSUG 2017 - Paper SS03 Use of Traceability Chains in Study Data and Metadata for Regulatory Electronic Submission ABSTRACT Tianshu Li, Celldex Therapeutics, Hampton, NJ Traceability is one of the
More informationAutomate Analysis Results Metadata in the Define-XML v2.0. Hong Qi, Majdoub Haloui, Larry Wu, Gregory T Golm Merck & Co., Inc.
Automate Analysis Results Metadata in the Define-XML v2.0 Hong Qi, Majdoub Haloui, Larry Wu, Gregory T Golm Merck & Co., Inc., USA 1 Topics Introduction Analysis Results Metadata (ARM) Version 1.0 o o
More informationIntroduction to ADaM and What s new in ADaM
Introduction to ADaM and What s new in ADaM Italian CDISC UN Day - Milan 27 th October 2017 Silvia Faini Principal Statistical Programmer CROS NT - Verona ADaM Purpose Why are standards needed in analysis
More informationSAS Application to Automate a Comprehensive Review of DEFINE and All of its Components
PharmaSUG 2017 - Paper AD19 SAS Application to Automate a Comprehensive Review of DEFINE and All of its Components Walter Hufford, Vincent Guo, and Mijun Hu, Novartis Pharmaceuticals Corporation ABSTRACT
More informationesubmission - Are you really Compliant?
ABSTRACT PharmaSUG 2018 - Paper SS21 esubmission - Are you really Compliant? Majdoub Haloui, Merck & Co., Inc., Upper Gwynedd, PA, USA Suhas R. Sanjee, Merck & Co., Inc., Upper Gwynedd, PA, USA Pinnacle
More informationGlobal Standards Information. Standards Simulation Training for the USG ICES Workshop. July 6, 2010
Global Standards Information Standards Simulation Training for the USG ICES Workshop July 6, 2010 Today s Discussion Why use a Standards Simulation Exercise? Role of the U.S. Government and NIST in standards
More informationSDTM-ETL 3.2 User Manual and Tutorial
SDTM-ETL 3.2 User Manual and Tutorial Author: Jozef Aerts, XML4Pharma Last update: 2017-07-29 Adding mappings for the Vital Signs domain After loading and validating the ODM file with metadata, your load
More information